Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent
暂无分享,去创建一个
M L Terrin | F. Barton | O. Castro | M. Steinberg | G. Dover | S. Charache | S. Ballas | E. Orringer | M. Terrin | R. Moore | R P McMahon | R D Moore | M H Steinberg | G J Dover | O Castro | S Charache | F B Barton | S K Ballas | E P Orringer | R. Mcmahon
[1] A. Kutlar,et al. Haplotypes of beta S chromosomes among patients with sickle cell anemia from Georgia. , 1986, Hemoglobin.
[2] F. Galactéros,et al. Fibrinogen, a modulator of erythrocyte adhesion to vascular endothelium. , 1983, The Journal of laboratory and clinical medicine.
[3] K. Wu,et al. The effect of spicules obtained from sickle red cells on clotting activity , 1984, British journal of haematology.
[4] S. Orkin,et al. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. , 1984, The Journal of clinical investigation.
[5] S. Chien,et al. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels , 1987, Transfusion.
[6] D. Labie,et al. Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. , 1985, The New England journal of medicine.
[7] J. L. Goodman,et al. Potentiated adherence of sickle erythrocytes to endothelium infected by virus. , 1987, The Journal of clinical investigation.
[8] Ernest W. Smith,et al. Sickle Cell-Hemoglobin D Disease. , 1959 .
[9] G. Serjeant,et al. The Irreversibly Sickled Cell; a Determinant of Haemolysis in Sickle Cell Anaemia , 1969, British journal of haematology.
[10] T. Huisman,et al. DNA sequence variation associated with elevated fetal G gamma globin production. , 1985, Blood.
[11] P. Levy,et al. Leg ulcers in patients with sickle cell disease. , 1989, Blood.
[12] O. Platt,et al. Membrane protein interactions in sickle red blood cells: evidence of abnormal protein 3 function. , 1995, Blood.
[13] R. Briehl,et al. Fragility and structure of hemoglobin S fibers and gels and their consequences for gelation kinetics and rheology , 1994 .
[14] T. Kinney,et al. Cooperative Study of Sickle Cell Disease: Demographic and socioeconomic characteristics of patients and families with sickle cell disease. , 1985, Journal of chronic diseases.
[15] D. Golan,et al. Adhesion of sickle neutrophils and erythrocytes to fibronectin. , 1996, Blood.
[16] A. Schechter,et al. The intracellular polymerization of sickle hemoglobin and its relevance to sickle cell disease. , 1981, Blood.
[17] V. Kalra,et al. Sickling-induced binding of immunoglobulin to sickle erythrocytes. , 1988, Blood.
[18] A. Chernoff,et al. Studies on abnormal hemoglobins. III. The interrelationship of type S (sickle cell) hemoglobin and type F (alkali resistant) hemoglobin in sickle cell anemia. , 1952, Blood.
[19] M. Reivich,et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. , 1984, Blood.
[20] J. Stuart,et al. Rheological changes in the prodromal and established phases of sickle cell vaso‐occlusive crisis , 1992, British journal of haematology.
[21] N. Mohandas,et al. Oxidation-induced changes in microrheologic properties of the red blood cell membrane. , 1990, Blood.
[22] M. Steinberg,et al. Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia. , 1984, Blood.
[23] George J. Dover,et al. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia [see comments] , 1992 .
[24] S. Edelstein. Molecular topology in crystals and fibers of hemoglobin S. , 1981, Journal of molecular biology.
[25] L. Sleeper,et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. , 1991, The New England journal of medicine.
[26] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[27] S. Charache,et al. Differences in the reaction sequences associated with drug-induced oxidation of hemoglobins E, S, A, and F. , 1983, The Journal of laboratory and clinical medicine.
[28] S. Lux,et al. Increased cation permeability in mutant mouse red blood cells with defective membrane skeletons. , 1995, Blood.
[29] M. Kay. Mechanism of removal of senescent cells by human macrophages in situ. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Hebbel,et al. Phagocytosis of sickle erythrocytes: immunologic and oxidative determinants of hemolytic anemia. , 1984, Blood.
[31] G. Wise,et al. Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures. , 1979, Blood.
[32] R. Schwartz,et al. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. , 1985, The Journal of clinical investigation.
[33] M. Steinberg,et al. Fetal hemoglobin in sickle cell anemia: relation to regulatory sequences cis to the beta-globin gene. Multicenter Study of Hydroxyurea. , 1996, Blood.
[34] S. Alper,et al. Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy. , 1996, Blood.
[35] S. Charache,et al. Fetal hemoglobin, sickling, and sickle cell disease. , 1990, Advances in pediatrics.
[36] O. Castro,et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. , 1994, Blood.
[37] T. Asakura,et al. Relationship between morphologic characteristics of sickle cells and method of deoxygenation. , 1984, The Journal of laboratory and clinical medicine.
[38] Y. C. Chang,et al. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2 , 1992 .
[39] B. Roelofsen,et al. Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells. , 1985, The Journal of clinical investigation.
[40] S. Ohnishi,et al. The mechanism of in vitro formation of irreversibly sickled cells and modes of action of its inhibitors. , 1986, Biochimica et biophysica acta.
[41] S. Zeger,et al. Longitudinal data analysis using generalized linear models , 1986 .
[42] W. Schroeder,et al. β-Cluster Haplotypes, α-Gene Status, and Hematological Data from SS, SC, and S-β-Thalassemia Patients in Southern California , 1989 .
[43] K. B. Ward,et al. Crystal structure of sickle-cell deoxyhemoglobin at 5 A resolution. , 1975, Journal of molecular biology.
[44] G. Stamatoyannopoulos,et al. Cellular distribution of hemoglobin F in a clonal hemopoietic stem-cell disorder. , 1978, The New England journal of medicine.
[45] R. Edalji,et al. Oxygen affinity as an index of hemoglobin S polymerization: a new micromethod. , 1978, Analytical biochemistry.
[46] J. White,et al. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. , 1980, The Journal of clinical investigation.
[47] W. Stock,et al. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis , 1996, American journal of hematology.
[48] C. Schalkwijk,et al. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. , 1996, Blood.
[49] J. White,et al. Pluronic F-68 reduces the endothelial adherence and improves the rheology of liganded sickle erythrocytes. , 1987, Blood.
[50] S. Shohet,et al. Erythrocyte Membrane Lipid Reorganization during the Sickling Process , 1979, British journal of haematology.
[51] A. Schechter,et al. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. , 1990, The New England journal of medicine.
[52] M. Karnovsky,et al. Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells. , 1976, The Journal of clinical investigation.
[53] H. Lipowsky,et al. Role of Leukocyte‐Endothelium Adhesion in Affecting Recovery from Ischemic Episodes a , 1989, Annals of the New York Academy of Sciences.
[54] M. Perutz. Structure and mechanism of haemoglobin. , 1976, British medical bulletin.
[55] G. Zimmerman,et al. Endothelial cell interactions with granulocytes: tethering and signaling molecules. , 1992, Immunology today.
[56] O. Platt,et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.
[57] G. Dover,et al. An analysis of fetal hemoglobin variation in sickle cell disease: the relative contributions of the X-linked factor, beta-globin haplotypes, alpha-globin gene number, gender, and age. , 1995, Blood.
[58] L. Benjamin,et al. Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia , 1995, American journal of hematology.
[59] E. Rappaport,et al. Rheologic predictors of the severity of the painful sickle cell crisis. , 1988, Blood.
[60] R. Hebbel,et al. Synergistic effects of oxidation and deformation on erythrocyte monovalent cation leak , 1990 .
[61] F. Barton,et al. Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. , 1995, Controlled clinical trials.
[62] C. Bauer,et al. Different effects of 2.3 diphosphoglycerate and adenosine triphosphate on the oxygen affinity of adult and foetal human haemoglobin , 1968 .
[63] R. Adams,et al. Cerebral infarction in sickle cell anemia , 1988, Neurology.
[64] D. Zwiers,et al. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[65] S. Alper,et al. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. , 1993, The Journal of clinical investigation.
[66] J. Smith,et al. Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease. , 1992, Journal of clinical epidemiology.
[67] P. Lauf,et al. Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells. , 1994, Blood.
[68] R. Briehl,et al. Kinetics of hemoglobin S polymerization and gelation under shear: I. Shape of the viscosity progress curve and dependence of delay time and reaction rate on shear rate and temperature. , 1993, Blood.
[69] D. Tosteson,et al. Regulation of erythrocyte cation and water content in sickle cell anemia. , 1986, Science.
[70] E. Rappaport,et al. The xerocytosis of Hb SC disease. , 1987, Blood.
[71] W. Dejong,et al. Hemoglobin O arab in four negro families and its interaction with hemoglobin S and hemoglobin C. , 1970, The New England journal of medicine.
[72] A. Fauci,et al. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. , 1976, Annals of internal medicine.
[73] W. T. Morgan,et al. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[74] P. McCurdy,et al. Irreversibly sickled cells and red cell survival in sickle cell anemia: a study with both DF32P and 51CR. , 1978, The American journal of medicine.
[75] J. Hofrichter,et al. Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[76] M L Terrin,et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. , 1995, The New England journal of medicine.
[77] G. Stamatoyannopoulos,et al. Stimulation of fetal hemoglobin production by short chain fatty acids. , 1995, Blood.
[78] G. Dover,et al. Progress toward Increasing Fetal Hemoglobin Production in Man: Experience with 5‐Azacytidine and Hydroxyurea a , 1985, Annals of the New York Academy of Sciences.
[79] E Vichinsky,et al. Pain in sickle cell disease. Rates and risk factors. , 1991, The New England journal of medicine.
[80] R. Hebbel,et al. Hydroxyl radical formation by sickle erythrocyte membranes: role of pathologic iron deposits and cytoplasmic reducing agents. , 1991, Blood.
[81] G. Dover,et al. Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. , 1987, Blood.
[82] Messer Mj,et al. Filtration characteristics of sickle cells: rates of alteration of filterability after deoxygenation and reoxygenation, and correlations with sickling and unsickling. , 1970 .
[83] L. Resar,et al. Cold water exposure and vaso-occlusive crises in sickle cell anemia. , 1991, The Journal of pediatrics.
[84] T. Ley,et al. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production. , 1986, Blood.
[85] C. Morris,et al. Deoxygenation-induced changes in sickle cell-sickle cell adhesion. , 1993, Blood.
[86] J. Eckman,et al. Molecular basis of sickle cell‐endothelial cell interactions , 1996, Current opinion in hematology.
[87] H. Meiselman,et al. Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst. , 1996, Blood.
[88] D. Richardson,et al. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. , 1995, Blood.